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ABSTRACT 
 
A series of new 3-aryl-4-phenyl-4,5-dihydroisoxazol-5-yl)ethanones (10-17) were synthesized by the 1,3-dipolar 
cycloaddition of benzalacetone and nitrile oxides generated in situ by the catalytic dehydrogenation of aromatic 
aldoximes using chloramine-T. The synthesised new compounds were tested for their antimicrobial susceptibility ‘ 
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INTRODUCTION 
 
The exploitation of a simple molecule with different functionalities for the synthesis of heterocycles is a worthwhile 
contribution in the chemistry. Heterocycles containing nitrogen and oxygen atom are considered as useful scaffolds 
for the synthesis of biologically active molecules. Among such classes of compounds isoxazolines occupies a prime 
position in medicinal chemistry for their diverse biological applications [1]. The larger intensity of biological 
potency exhibited by isoxazoline moiety stimulated the researchers work in this area to develop new novel synthetic 
approaches for their synthesis and study their activity. Of the methods developed, 1,3-dipolar cycloaddition of nitrile 
oxides to alkenes was most commonly employed for its easy and accessible procedure. The recent reviews reported 
on Huisgen cycloaddition reactions and nitrile oxides completely describes the method of synthesizing isoxazolines, 
stereochemistry, mechanistic considerations of 1,3-dipolar cycloaddition reactions [2-3]. 
 
Isoxazolines were synthesized by the sequential reaction of ketones with arylacetylenes and hydroxylamine in the 
presence of KOBut/DMSO followed by the treatment of the reaction mixture with H2O and KOH leads to ∆2-
isoxazolines in good yields [4], by 1,3-dipolar cycloaddition of in situ generated nitrile oxide with alkenes [5], and 
by the reaction of unprotected O-propargylic hydroxylamines on cyclisations by exposing briefly to silver nitrate 
adsorbed onto silica gel [6]. The isoxazoles acts as selective cyclooxygenase-2 (COX-2) inhibitory antiinflammatory 
(AI) agents [7], antimicrobials [8], anti-arthritic and anti-inflammatory [9], and anti-tuberculosis [10] agents. 
 
In search of potential antioxidants agents; herein we report the present study of synthesis and in vitro screening for 
antioxidant activities of series of new isoxazolines. The synthesis of series of mixture of isoxazolines (3) major and 
(4) minor products involve 1,3-dipoar cycloaddition of benzalacetone (2) and nitrile imines generated in situ from 
aldoximes (2) using chloramine-T (CAT) as catalytic dehydrogenating agent. The synthesized new compounds have 
been evaluated in vitro for their DPPH radical scavenging ability. 
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EXPERIMENTAL SECTION 
 
The chemicals/reagents used were purchased from Sigma-Aldrich Chemicals (India) and Merck Chemicals (India). 
IR spectra were recorded on a Nujol mull on a Shimadzu 8300 spectrometer. The 1H NMR and 13C NMR spectra 
were recorded on a Bruker Supercon 400 MHz spectrophotometer using CDCl3 as solvent and TMS as an internal 
standard. The chemical shifts are expressed in δ ppm. Mass spectra were obtained on a Shimadzu LCMS-2010A 
spectrophotometer (chemical ionization) and the important fragments are given with the relative intensities in the 
bracket. Elemental analysis was obtained on a Thermo Finnigan Flash EA 1112 CHN analyzer. Thin layer 
chromatography (TLC) was performed on precoated silica gel sheets (HF 254, sd-fine) using benzene:ethyl acetate 
(7:2) eluent, and visualization of the spots was done in iodine vapor and UV light. Chromatographic separations 
were carried out on a silica gel column (70-230 mesh, Merck) using hexane:ethyl acetate (8:1) as the eluent. 
 
In a typical 1,3-dipolar cycloaddition reaction, the nitrile oxides generated by the catalytic dehydrogenation of 
aromatic aldoximes (2a-h) with chloramine-T in ethyl alcohol were trapped in situ with benzalacetone (1), the 
reaction yielded an isomeric mixture of  3-aryl-4-phenyl-4,5-dihydroisoxazol-5-yl)ethanones (3a-h) as major and 3-
aryl-5-phenyl-4,5-dihydroisoxazol-4-yl)ethanones (4a-h) as minor products (Scheme-1). 
 
 
 
General procedure for dipolar cycloaddition:  
A mixture of aromatic aldehoximes 2a-h (4.0 mmol), benzalacetone 1 (4.0 mmol) and chloramine-T trihydrate (5.0 
mmol) in ethanol was refluxed in a water bath for 3 hours. The progress of the reaction was monitored by TLC. 
After the completion of the reaction, the sodium chloride formed was filtered off, and the filtrate was evaporated in 
vacuo. The residual mass was extracted into ether (25 mL) and washed successively with water (2 x 15 mL), 10% 
sodium hydroxide (2 x 15 mL) and saturated brine solution (1 x 10 mL). The organic layer was dried over anhydrous 
sodium sulfate. The organic layer was dried over anhydrous sodium sulphate and the solvent was evaporated to 
dryness. The reaction produced light to brown oily mass, which showed two spot corresponding to the cycloadducts 
(3 and 4) in TLC. The products were separated by column chromatography using benzene: ethyl acetate (8:3 v/v) as 
eluent.  
 
Antioxidant activity  
The capacity to scavenge the stable free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) was monitored according to 
the Blois method [11] using ascorbic acid as standard antioxidant. Samples dissolved in methanol (0-50 µg/mL; 0-5 
µg/mL ascorbic acid) in 200 µL aliquot was mixed with 100 mM tris-HCl buffer (800 µL, pH 7.4) and then added 1 
mL of 500 µM DPPH in ethanol (final concentration of 250 µM). The mixture was shaken vigorously and left to 
stand for 20 min at room temperature in the dark. The absorbance of the resulting solution was measured 
spectrophotometrically at 517 nm. The experiments were performed in triplicates; the results are expressed as mean 
± standard deviation (SD). 
 
RESULTS AND DISCUSSION 
 
3,4-Diphenyl-4,5-dihydroisoxazol-5-yl)ethanone, 3a: Obtained as pale yellow oil in 72% yield. IR (Nujol): 1634 
(C=N str.), 1682 (C=O str.) cm-1. 1H NMR (CDCl3):  δ 2.276 (s, 3H, CH3), 4.452 (d, 1H, C4-H), 4.823 (d, 1H, C5-H), 
7.269-7.705 (m, 10H, Ph-, Ar-H). 13C NMR (CDCl3):  δ 26.54 (1C, CH3), 27.52 (1C, 4-C), 85.98 (1C, 5-C), 125.24 
(1C, Ph-C), 127.53 (1C, Ph-C), 127.54 (1C, Ph-C), 128.02 (1C, Ar-C), 128.18 (1C, Ar-C), 128.68 (1C, Ph-C), 
128.71 (1C, Ph-C), 128.95 (1C, Ar-C), 128.99 (1C, Ar-C), 130.69 (1C, Ar-C), 134.44 (1C, Ar-C), 139.62 (1C, Ph-
C), 158.81 (1C, 3-C), 207.35 (1C, C=O). MS (relative abundance) m/z: 266 (MH+, 100), 265 (M+, 20), 250 (10), 236 
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(16), 222 (12), 220 (26). Anal. Calcd. for C17H15NO2: C, 76.96, H, 5.70, N, 5.28%; Found: C, 76.91, H, 5.71, N, 
5.22%. 
 
3-(4-Methoxyphenyl)-4-phenyl-4,5-dihydroisoxazol-5-yl)ethanone, 3b: Obtained as pale yellow oil in 79% yield. 
IR (Nujol): 1630 (C=N str.), 1690 (C=O str.) cm-1. 1H NMR (CDCl3):  δ 2.202 (s, 3H, CH3), 3.832 (s, 3H, OCH3), 
4.322 (d, 1H, C4-H), 4.720 (d, 1H, C5-H), 7.106 (dd, 2H, Ar-H), 7.269-7.405 (m, 5H, Ph-H), 7.901 (dd, 2H, Ar-H). 
13C NMR (CDCl3):  δ 26.20 (1C, CH3), 28.02 (1C, 4-C), 55.72 (1C, OCH3), 88.70 (1C, 5-C), 114.28 (2C, Ar-C), 
125.30 (1C, Ph-C), 126.90 (1C, Ar-C), 127.62 (2C, Ph-C), 128.38 (2C, Ar-C), 128.64 (2C, Ph-C), 140.12 (1C, Ph-
C), 159.96 (1C, 3-C), 161.25 (1C, Ar-C), 207.20 (1C, C=O). MS (relative abundance) m/z: 296 (MH+, 100), 295 
(M+, 18), 280 (14), 266 (20), 252 (10), 250 (32). Anal. Calcd. for C18H17NO3: C, 73.20, H, 5.80, N, 4.74%; Found: 
C, 73.12, H, 5.71, N, 4.70%. 
 
3-(3,4-Dimethoxyphenyl)-4-phenyl-4,5-dihydroisoxazol-5-yl)ethanone, 3c: Obtained as pale yellow oil in 71% 
yield. IR (Nujol): 1640 (C=N str.), 1693 (C=O str.) cm-1. 1H NMR (CDCl3):  δ 2.130 (s, 3H, CH3), 3.840 (s, 6H, 
OCH3), 4.380 (d, 1H, C4-H), 4.708 (d, 1H, C5-H), 7.010-7.415  (m, 8H, Ph-, Ar-H). 13C NMR (CDCl3):  δ 26.00 
(1C, CH3), 28.30 (1C, 4-C), 55.92 (2C, OCH3), 88.82 (1C, 5-C), 112.18 (1C, Ar-C), 114.70 (1C, Ar-C), 120.55 (1C, 
Ar-C), 125.36 (1C, Ph-C), 127.40 (1C, Ar-C), 127.72 (2C, Ph-C), 128.88 (2C, Ph-C), 140.06 (1C, Ph-C), 148.20 
(1C, Ar-C), 151.36 (1C, Ar-C), 160.10 (1C, 3-C), 207.18 (1C, C=O). MS (relative abundance) m/z: 326 (MH+, 100), 
325 (M+, 12), 310 (8), 296 (10), 282 (8), 280 (24), 206 (8). Anal. Calcd. for C19H19NO4: C, 70.14; H, 5.89; N, 
4.31%; Found: C, 70.20; H, 5.84; N, 4.30%.  
 
3-(4-Methylphenyl)-4-phenyl--4,5-dihydroisoxazol-5-yl)ethanone, 3d: Obtained as pale yellow oil in 86% yield. IR 
(Nujol): 1635 (C=N str.), 1684 (C=O str.) cm-1. 1H NMR (CDCl3):  δ 2.214 (s, 3H, CH3), 2.480 (s, 3H, CH3), 4.316 
(d, 1H, C4-H), 4.698 (d, 1H, C5-H), 7.202 (dd, 2H, Ar-H), 7.280-7.422 (m, 5H, Ph-H), 7.706 (dd, 2H, Ar-H). 13C 
NMR (CDCl3):  δ 21.72 (1C, CH3), 26.02 (1C, CH3), 28.36 (1C, 4-C), 88.66 (1C, 5-C), 125.44 (1C, Ph-C), 127.10 
(2C, Ar-C), 127.58 (2C, Ph-C), 128.50 (2C, Ph-C), 129.34 (2C, Ar-C), 131.80 (1C, Ar-C), 139.90 (1C, Ar-C), 
140.04 (1C, Ph-C), 160.82 (1C, 3-C), 207.04 (1C, C=O). Anal. Cacld. for C18H17NO2: C, 77.40; H, 6.13; N, 5.01%; 
Found: C, 77.46; H, 6.12; N, 5.06%. 
 
3-(4-Fluorophenyl)-4-phenyl-4,5-dihydroisoxazol-5-yl)ethanone, 3e: Obtained as pale yellow oil in 86% yield. IR 
(Nujol): 1638 (C=N str.), 1678 (C=O str.) cm-1. 1H NMR (CDCl3):  δ 2.218 (s, 3H, CH3), 4.292 (d, 1H, C4-H), 4.580 
(d, 1H, C5-H), 7.366 (dd, 2H, Ar-H), 7.259-7.380 (m, 5H, Ph-H), 7.821 (dd, 2H, Ar-H). 13C NMR (CDCl3):  δ 25.88 
(1C, CH3), 28.10 (1C, 4-C), 89.15 (1C, 5-C), 115.32 (2C, Ar-C), 126.06 (1C, Ph-C), 127.51 (2C, Ph-C), 128.48 (2C, 
Ph-C), 128.94 (2C, Ar-C), 129.40 (1C, Ar-C), 140.10 (1C, Ph-C), 159.86 (1C, 3-C), 163.20 (1C, Ar-C), 207.38 (1C, 
C=O). MS (relative abundance) m/z: 284 (MH+, 100), 283 (M+, 10), 368 (12), 354 (14), 340 (13), 338 (22). Anal. 
Calcd. for C17H14FNO2: C, 72.07; H, 4.98; N, 4.94%; Found: C, 72.07; H, 4.93; N, 4.90%. 
 
3-(4-Chlorophenyl)-4-phenyl-4,5-dihydroisoxazol-5-yl)ethanone, 3f: Obtained as pale yellow oil in 78% yield. IR 
(Nujol): 1640 (C=N str.), 1695 (C=O str.) cm-1. 1H NMR (CDCl3):  δ 2.230 (s, 3H, CH3), 4.301 (d, 1H, C4-H), 4.670 
(d, 1H, C5-H), 7.240-7.385 (m, 5H, Ph-H), 7.506 (dd, 2H, Ar-H), 7.980 (dd, 2H, Ar-H). 13C NMR (CDCl3):  δ 26.14 
(1C, CH3), 28.16 (1C, 4-C), 88.86 (1C, 5-C), 125.88 (1C, Ph-C), 127.22 (2C, Ph-C), 128.02 (2C, Ar-C), 128.52 (2C, 
Ph-C), 128.80 (2C, Ar-C), 132.74 (1C, Ar-C), 135.92 (1C, Ar-C), 141.00 (1C, Ph-C), 160.36 (1C, 3-C), 207.02 (1C, 
C=O). MS (relative abundance) m/z: 301 (M+, 37Cl, 33), 299 (M+, 35Cl, 100), 284 (08), 270 (18), 256 (16), 254 (06). 
Anal. Calcd. for C17H14ClNO2: C, 68.12; H, 4.71; N, 4.67%; Found: C, 68.18; H, 4.79; N, 4.64%. 
 
3-(4-Bromophenyl)-4-phenyl-4,5-dihydroisoxazol-5-yl)ethanone, 3g: Obtained as white solid in 78% yield, m.p 
105-106ºC. IR (Nujol): 1641 (C=N str.), 1688 (C=O str.) cm-1. 1H NMR (CDCl3):  δ 2.230 (s, 3H, CH3), 4.398 (d, 
1H, C4-H), 4.744 (d, 1H, C5-H), 7.436 (dd, 2H, Ar-H), 7.230-7.442 (m, 5H, Ph-H), 7.790 (dd, 2H, Ar-H). Anal. 
Calcd. for C17H14BrNO2: C, 59.32; H, 4.10; N, 4.07%; Found: C, 59.30; H, 4.14; N, 4.03%.  
 
3-(4-Nitrophenyl)-4-phenyl-4,5-dihydroisoxazol-5-yl)ethanone, 3h: Obtained as pale yellow oil in 70% yield. IR 
(Nujol): 1645 (C=N str.), 1683 (C=O str.) cm-1. 1H NMR (CDCl3):  δ 2.248 (s, 3H, CH3), 4.375 (d, 1H, C4-H), 4.688 
(d, 1H, C5-H), 7.310-7.486 (m, 5H, Ph-H), 8.010 (dd, 2H, Ar-H), 8.341 (dd, 2H, Ar-H). 13C NMR (CDCl3):  δ 26.14 
(1C, CH3), 29.16 (1C, 4-C), 89.08 (1C, 5-C), 125.14 (1C, Ph-C),  127.12 (2C, Ar-C), 127.34 (2C, Ph-C), 127.82 
(2C, Ar-C), 128.56 (2C, Ph-C), 139.20 (1C, Ar-C), 140.05 (1C, Ph-C), 152.10 (1C, Ar-C), 159.72 (1C, 3-C), 207.28 
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(1C, C=O). MS (relative abundance) m/z: 311 (MH+, 100), 310 (M+, 12), 295 (16), 281 (22), 267 (10), 265 (09). 
Anal. Calcd. for C17H14N2O4: C, 65.80, H, 4.55, N, 9.03%; Found: C, 65.86, H, 4.50, N, 9.07%. 
 
The physical and analytical data of the two isomeric minor products 4d and 4e were given below. 
 
3-(4-Methylphenyl)-5-phenyl--4,5-dihydroisoxazol-4-yl)ethanone, 4d: Obtained as pale yellow oil in 12% yield. IR 
(Nujol): 1630 (C=N str.), 1680 (C=O str.) cm-1. 1H NMR (CDCl3):  δ 2.222 (s, 3H, CH3), 2.412 (s, 3H, CH3), 4.304 
(d, 1H, C4-H), 4.660 (d, 1H, C5-H), 7.112 (dd, 2H, Ar-H), 7.240-7.332 (m, 5H, Ph-H), 7.754 (dd, 2H, Ar-H). 13C 
NMR (CDCl3):  δ 21.34 (1C, CH3), 26.32 (1C, CH3), 28.44 (1C, 4-C), 88.56 (1C, 5-C), 125.50 (1C, Ph-C), 127.00 
(2C, Ar-C), 127.60 (2C, Ph-C), 128.80 (2C, Ph-C), 129.56 (2C, Ar-C), 131.79 (1C, Ar-C), 138.10 (1C, Ar-C), 
140.66 (1C, Ph-C), 161.12 (1C, 3-C), 203.14 (1C, C=O). Anal. Cacld. for C18H17NO2: C, 77.40; H, 6.13; N, 5.01%; 
Found: C, 77.52; H, 6.04; N, 5.03%. 
 
3-(4-Fluorophenyl)-5-phenyl-4,5-dihydroisoxazol-4-yl)ethanone, 4e: Obtained as pale yellow oil in 16% yield. IR 
(Nujol): 1645 (C=N str.), 1680 (C=O str.) cm-1. 1H NMR (CDCl3):  δ 2.328 (s, 3H, CH3), 4.442 (d, 1H, C4-H), 4.590 
(d, 1H, C5-H), 7.426 (dd, 2H, Ar-H), 7.280-7.460 (m, 5H, Ph-H), 7.846 (dd, 2H, Ar-H). 13C NMR (CDCl3):  δ 24.80 
(1C, CH3), 28.16 (1C, 4-C), 89.30 (1C, 5-C), 115.40 (2C, Ar-C), 126.22 (1C, Ph-C), 127.66 (2C, Ph-C), 128.67 (2C, 
Ph-C), 128.90 (2C, Ar-C), 129.20 (1C, Ar-C), 140.45 (1C, Ph-C), 159.96 (1C, 3-C), 163.00 (1C, Ar-C), 204.30 (1C, 
C=O). MS (relative abundance) m/z: 284 (MH+, 100), 283 (M+, 14), 368 (20), 354 (22), 340 (18), 338 (22). Anal. 
Calcd. for C17H14FNO2: C, 72.07; H, 4.98; N, 4.94%; Found: C, 72.17; H, 4.90; N, 4.86%. 
 
The structures of the cycloadducts were provided by IR, 1H NMR, 13C NMR, MS spectral studies and elemental 
analysis. In IR spectrum of the cycloadducts (3a-h), a strong absorption bands in the region 1630-1645 cm-1 and in 
the region 1678-1695 cm-1, these absorptions bands were assigned to C=N (str) and C=O (str) frequencies 
respectively.   
 
In 1H NMR spectra, all the new products (3a-h) showed the peaks due to aromatic and substituent protons at the 
expected region. The consistent pattern signals due to C4-H and C5-H appeared as doublet in the region δ 4.122-
4.240 ppm. and δ 4.390-4.491 ppm. The coupling constant (J) values obtained were in range 6.8-9.4 Hz; indicating 
that both C4-H and C5-H are in cis fashion. 
 
In 13C NMR, all products gave the signals due to aromatic and substituent carbons at the expected region. The 
signals due to newly formed C4-carbon appeared in the region δc 41.56-41.88 ppm, while, C5-carbon showed the 
signals in the region δc 51.24-51.92 ppm. The signals due to CN group carbon appear in the region δc 116.2-118.0 
ppm which shows that the CN triple bond is unaffected during cycloaddition and is retained in the product. The new 
compounds (3a-h) gave significantly stable molecular ion peaks with a relative abundance ranging up to 40% and 
base peak at (MH+). Further, all showed satisfactorily CHN analysis with a deviation of ±0.02% from the 
theoretically calculated values. All these observations strongly favor the formation of the cycloadducts. 
 
The results of antioxidant activity of the synthesized compounds against different bacterium were tabulated in 
Table-1. 
  
The compounds 3a-g showed promising free radical scavenging ability but of lesser activity compared with the 
standard antioxidant. No much significant variations in the free radical scavenging ability were observed at the 
initial concentrations of (10-20 µg/mL). However, at the higher concentrations (30-50 µg/mL) all showed a 
promising activity. Among the series of synthesized compounds 3f having chloro substitution in the aromatic ring 
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howed radical scavenging ability up to 58%, while the compounds 3a and 3e having no and fluro substitution in the 
aromatic ring showed radical scavenging ability of 44% and 46% respectively. 
 
Table-1: DPPH Radical Scavenging activity of the compounds 3a-g relative to the standard ascorbic acid 
Samples 
% Radical Scavenging activity 
Concentration (µg/mL) 
10 20 30 40 50 
3a 12.76 ± 0.94 15.23 ± 0.88 29.20 ± 0.71 39.66 ± 0.98 44.17 ± 0.82 
3b 13.16 ± 0.80 17.25 ± 0.90 26.92 ± 0.96 31.60 ± 0.95 36.00 ± 0.88 
3c 17.30 ± 0.89 24.28 ± 0.79 29.36 ± 0.97 32.22 ± 0.78 35.16 ± 0.82 
3d 12.22 ± 0.85 14.92 ± 0.89 22.61 ± 0.68 29.96 ± 0.91 33.61 ± 0.75 
3e 13.46 ± 0.82 23.30 ± 0.89 29.88 ± 0.81 37.52 ± 0.98 46.73 ± 0.83 
3f 15.16 ± 0.78 28.36 ± 0.92 37.42 ± 0.83 46.23 ± 0.78 58.42 ± 0.99 
3g 09.32 ± 0.86 14.36 ± 0.98 17.23 ± 0.91 20.70 ± 0.79 22.40 ± 0.91 
3h 08.12 ± 0.88 11.36 ± 0.98 14.80 ± 0.81 18.50 ± 0.70 20.20 ± 0.76 
Control at Concentration 0 µg/mL 0.00 ± 0.00 
*Values are expressed as mean ± standard deviation (n=3) 
 
The compounds 3g and 3h having bromo substitution in the aromatic ring and furan ring in place of aromatic ring 
exhibited least activity (up to 22%) of the synthesized compounds with reference to the standard antioxidant. While 
the compounds 3b, 3c, 3d containing a strong electron donating groups such as methyl and methoxy substitution in 
the aromatic ring showed moderate scavenging ability 33-36%. 
 
CONCLUSION 
 
The easy and accessible procedure for the synthesis of new isoxazolines and their antioxidant activity results 
validates the significance of this study. The study revealed that the most of the compounds tested showed moderate 
to good antioxidant activities. However, the SAR studies of the synthesized compounds for their antioxidant activity 
remains to be studied. 
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